Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-24-001976

Options or other derivatives

  • EVP, Chief Development Officer acquired 433,924 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Forbes William P EVP, Chief Development Officer 2024-01-19 Grant or award · Employee Stock Option (Right to Buy) +371,935 371,935 D: show line 1 in the form
Forbes William P EVP, Chief Development Officer 2024-01-19 Grant or award · Restricted Stock Units +61,989 61,989 D: show line 2 in the form
Loading xslF345X05/doc4.xml…